New research finds that measuring water loss through the skin during food challenges can predict anaphylaxis before symptoms appear, increasing patient comfort and safety.

Researches in the US have completed a trial examining the safety and efficacy of sublingual immunotherapy and found it has potential for long lasting effects and is most effective in young children.

The biopharmaceutical company DBV Technologies is due to begin two safety trials for Viaskin Peanut in two age groups, known as COMFORT Toddlers and COMFORT Children.

Researchers based at Birmingham Heartlands Hospital are inviting health professionals to take part in The FAIR Study to benefit patients from a South Asian Background with food allergies.

A small study has shown that a cancer drug called acalabrutinib improves tolerance to peanuts in the short term, making it the first drug to achieve rapid-onset prevention of IgE-induced food reactivity.

A new study published in Scientific Reports this October suggests that the asthma treatments omalizumab, benralizumab and mepolizumab are linked to a higher risk of anaphylactic reactions than other similar drugs.

Several studies have now been published to provide the prevalence estimates of food allergy and food sensitisation to the most common foods in Europe – cow’s milk, egg, wheat, soy, peanut, tree nuts, fish and shellfish.

A new article by Dr Paul Turner, an eminent authority on allergies at Imperial College, London and member of the Anaphylaxis UK Clinical & Scientific Panel states that the risk of a reaction for an individual with a food allergy on

A new position paper from the European Academy of Allergy and Clinical Immunology, titled “Allergy to Stings and Bites from Rare or Locally Important Arthropods: Worldwide Distribution, Available Diagnostics, and Treatment,” offers detailed information for healthcare professionals on insect stings and bites and their potential to trigger serious systemic allergic reactions.